Plasma Cytokine and Angiogenic Factor Profiling Identifies Markers Associated With Tumor Shrinkage in Early-Stage Non-Small Cell Lung Cancer Patients Treated With Pazopanib

Cancer Research - United States
doi 10.1158/0008-5472.can-09-2533
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Correction: Methylation Markers of Early-Stage Non-Small Cell Lung Cancer

PLoS ONE
Multidisciplinary
2017English

RACK1 Is a Candidate Gene Associated With the Prognosis of Patients With Early Stage Non-Small Cell Lung Cancer

Oncotarget
Oncology
2015English

Dynamic Changes of Phenotypically Different Circulating Tumor Cells Sub-Populations in Patients With Recurrent/Refractory Small Cell Lung Cancer Treated With Pazopanib

Scientific Reports
Multidisciplinary
2018English

108P: Genetic Polymorphisms in Glycolytic Pathway Are Associated With the Prognosis of Patients With Early Stage Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

Effects of Biological Markers on Overall Survival in Surgically Treated Patients With Non Small Cell Lung Cancer

Vojnosanitetski Pregled
MedicinePharmacology
2020English

P1.04-03 Suppressive Immune Cell Profiling in Patients With Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

An Evaluation of Tumor Oxygenation and Gene Expression in Patients With Early Stage Non-Small Cell Lung Cancers

Clinical Cancer Research
Cancer ResearchOncology
2006English

Cytokine Release Syndrome With Pseudoprogression in a Patient With Advanced Non–Small Cell Lung Cancer Treated With Pembrolizumab

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2019English

Role of Surgery in Patients With Early Stage Small-Cell Lung Cancer [Erratum]

Cancer Management and Research
Oncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy